Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boostrix Booster 10 Years Post-Previous Boost
NCT00610168Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2008
- Primary completion
- Apr 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) in diphtheria, Tetanus, pertussis, sponsored by GSK. Started Jan 2008; status: completed.
02
Drugs
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on NCT00610168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610168.